Big Pharma’s China gamble

US House Speaker Mike Johnson sent home Congress members early to avoid a vote on releasing files on Jeffery Epstein, Nigeria’s recalculated GDP reflects a 30 per cent growth of its economy, and US President Donald Trump’s tariffs have hit General Motors' profits. Plus, global pharma companies have spent a record amount on Chinese biotech this year and Coca-Cola is putting cane sugar back in Coke.Mentioned in this podcast:Mike Johnson shuts US House early to avoid Epstein voteNigeria’s economy 30% bigger after GDP recalculation Big Pharma is increasingly reliant on Chinese biotech advancesGM profits hit by Trump’s tariffs while EV sales more than doubleCoca-Cola to launch cane sugar-based Coke in US this autumnToday’s FT News Briefing was produced by Sonja Hutson, Katya Kumkova, and Marc Filippino. Additional help from Kelly Garry and Michael Lello. Our acting co-head of audio is Topher Forhecz. Our intern is Michaela Seah. The show’s theme song is by Metaphor Music.Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.